Showing results (121-130 of 231) with videos related to
Sort By:
Pageof 24
Oncogene|January 27, 2010
Alternative splicing of p53 and p73: the novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancerG Hofstetter, A Berger, H Fiegl, et al.Clinical Chemistry|December 1, 1988
An improved solid-phase enzyme and luminescent immunoassay system for steroid hormones and digoxinW Hubl, G Daxenbichler, D Meissner, et al.Anticancer Research|September 2, 1999
Increased neopterin concentrations in patients with cancer: indicator of oxidative stress?C Murr, L C Fuith, B Widner, et al.Wiener Klinische Wochenschrift|January 1, 1991
[Analysis of polycyclic aromatic hydrocarbons in lipid-containing biological matrices--study of contamination of breast milk by benzo(a)pyrene along transit routes through Tyrol]W Lechner, M Huber, G K Bonn, et al.Gynecologic and Obstetric Investigation|January 1, 1989
Calcium antagonists for uterine relaxationW Lechner, C Marth, F KeeneGeburtshilfe Und Frauenheilkunde|August 1, 1992
[Steroid and protein hormone concentrations in serum and follicular fluid after stimulation for in vitro fertilization]H Zech, P Weiss, H Fritzsche, et al.Gynakologische Rundschau|January 1, 1990
[Inhibition of spontaneous uterine contractions by magnesium. Magnesium tocolysis]W Lechner, P Mayr, C MarthOnkologie|April 1, 1985
[Comparison between the biochemical and histochemical determination of hormone receptors in breast carcinomas]D Manfreda, H Aigner, G Daxenbichler, et al.European Journal of Cancer (Oxford, England : 1990)|November 1, 2000
Tamoxifen in the treatment of recurrent ovarian carcinomaC Tropé, C Marth, J KaernCancer Research|September 15, 1987
Clinical significance of neopterin for prognosis and follow-up in ovarian cancerG Reibnegger, H Hetzel, D Fuchs, et al.Pageof 24